Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

14.37
+0.70005.12%
Post-market: 14.20-0.1740-1.21%19:30 EDT
Volume:668.30K
Turnover:9.58M
Market Cap:1.21B
PE:18.37
High:14.47
Open:13.78
Low:13.72
Close:13.67
52wk High:15.89
52wk Low:6.26
Shares:84.09M
Float Shares:33.47M
Volume Ratio:1.32
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7821
EPS(LYR):0.3300
ROE:25.68%
ROA:5.49%
PB:5.29
PE(LYR):43.55

Loading ...

Bravura flags isolated late filing of director share change

TIPRANKS
·
Yesterday

Bravura Solutions Signals Profitable Momentum In FY2026

TIPRANKS
·
Aug 26

Bravura Solutions (ASX:BVS) Is Down 8.1% After Announcing A$50m Buyback And Special Dividend – What's Changed

Simply Wall St.
·
Aug 24

Bioventus Earnings Call Highlights Growth Amid Review

TIPRANKS
·
Aug 21

Cantor Fitzgerald Reaffirms Their Buy Rating on Bioventus (BVS)

TIPRANKS
·
Aug 17

Bioventus Price Target Maintained with a $15.00/Share by Cantor Fitzgerald

Dow Jones
·
Aug 17

Bravura Solutions (ASX:BVS) Could Be 21% Overvalued As Buyback And Dividends Lift Sentiment

Simply Wall St.
·
Aug 17

Bravura Solutions Updates Market on Issue and Conversion of Unquoted Securities

TIPRANKS
·
Aug 17

Why Bravura Solutions (ASX:BVS) Is Up 28.2% After Launching a Major Buyback and Dividend Boost

Simply Wall St.
·
Aug 15

Bravura Solutions Reshapes Finance and Governance Leadership

TIPRANKS
·
Aug 14

Bravura Solutions (ASX:BVS) Shares Reflect Margin Gains But Churn Questions Linger

Simply Wall St.
·
Aug 13

Bravura Solutions Limited (BVS) Receives a Buy from Shaw and Partners

TIPRANKS
·
Aug 13

Macquarie Sticks to Their Hold Rating for Bravura Solutions Limited (BVS)

TIPRANKS
·
Aug 13

Bravura Solutions Updates Governance Framework to Align With ASX Best Practice

TIPRANKS
·
Aug 12

Bravura Solutions Declares AUD 0.15 Interim Dividend for Half-Year to June 2026

TIPRANKS
·
Aug 12

Barrington Adjusts Price Target on Bioventus to $18 From $14, Maintains Outperform Rating

MT Newswires Live
·
Aug 06

Bioventus Fiscal Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Reaffirmed

MT Newswires Live
·
Aug 05

Bioventus Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Bioventus Q2 Revenue Misses Estimates on Surgical Solutions Decline

Reuters
·
Aug 05

GUIDANCE: (BVS) Bioventus Expects Full Year 2026 Revenue Range 600M-$610M, vs. FactSet Est of $605.3M

MT Newswires Live
·
Aug 05